These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 10401760)
21. Role of endothelin-converting enzyme in the systemic hemodynamics and regional circulatory effects of proendothelin-1 (1-38) and diaspirin cross-linked hemoglobin in rats. Gulati A; Singh R; Chung SM; Sen AP J Lab Clin Med; 1995 Dec; 126(6):559-70. PubMed ID: 7490515 [TBL] [Abstract][Full Text] [Related]
22. Endothelin-1, endothelin-3 and their receptors (endothelin(A) and endothelin(B)) in chronic renal transplant rejection in rats. Deng DX; Jiang J; Garcia B; Zhong R; Chakrabarti S Transpl Int; 2000; 13(3):175-82. PubMed ID: 10935699 [TBL] [Abstract][Full Text] [Related]
23. New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model. Richter M; Skupin M; Grabs R; Schramm D; Richter H; Olbrich HG J Heart Lung Transplant; 2000 Nov; 19(11):1047-55. PubMed ID: 11077221 [TBL] [Abstract][Full Text] [Related]
24. Effects of inhibition of poly(adenosine diphosphate-ribose) synthase on acute cardiac allograft rejection. Liu Y; Son NH; Szabolcs MJ; Ma N; Sciacca RR; Albala A; Edwards N; Cannon PJ Transplantation; 2004 Sep; 78(5):668-74. PubMed ID: 15371666 [TBL] [Abstract][Full Text] [Related]
25. Initial T-cell activation required for transplant vasculopathy in retransplanted rat cardiac allografts. Tori M; Kitagawa-Sakakida S; Li Z; Izutani H; Horiguchi K; Ito T; Matsuda H; Shirakura R Transplantation; 2000 Sep; 70(5):737-46. PubMed ID: 11003350 [TBL] [Abstract][Full Text] [Related]
26. Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease. Takami H; Backer CL; Crawford SE; Pahl E; Mavroudis C J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):67-77. PubMed ID: 8820085 [TBL] [Abstract][Full Text] [Related]
27. Cyclosporin A does not enhance the development of transplant vasculopathy: experimental study in a rat cardiac transplant model. Richter MH; Richter H; Barten M; Schramm D; Weinert M; Gummert J; Mohr FW; Olbrich HG Transplant Proc; 2002 Aug; 34(5):1479-80. PubMed ID: 12176448 [No Abstract] [Full Text] [Related]
28. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection. Schmid C; Heemann U; Azuma H; Tilney NL Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053 [No Abstract] [Full Text] [Related]
29. Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant vasculopathy in different aorta allotransplantation rat models. Orth SR; Odoni G; Karkoszka H; Ogata H; Viedt C; Amann K; Ferrari P; Ritz E Nephrol Dial Transplant; 2003 Jan; 18(1):62-9. PubMed ID: 12480961 [TBL] [Abstract][Full Text] [Related]
30. Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation. Shen J; Chong AS; Xiao F; Liu W; Huang W; Blinder L; Foster P; Sankary H; Jensik S; McChesney L; Mital D; Williams JW Transplantation; 1998 Sep; 66(6):692-8. PubMed ID: 9771831 [TBL] [Abstract][Full Text] [Related]